These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Optimization of dosing regimens and dosing in special populations. Sime FB; Roberts MS; Roberts JA Clin Microbiol Infect; 2015 Oct; 21(10):886-93. PubMed ID: 25980350 [TBL] [Abstract][Full Text] [Related]
14. [N1-metal sulfa drugs and zincpolyanemine and its derivatives in prevention of burn wound sepsis]. Ge SD Zhonghua Wai Ke Za Zhi; 1982 May; 20(5):264-6. PubMed ID: 7128331 [No Abstract] [Full Text] [Related]
15. Determination of tobramycin pharmacokinetics in burn patients to evaluate the potential utility of once-daily dosing in this population. Vella D; Walker SA; Walker SE; Daneman N; Simor A J Burn Care Res; 2014; 35(4):e240-9. PubMed ID: 24043237 [TBL] [Abstract][Full Text] [Related]
16. The use of oral antibiotic suppression for control of infections in patients with thermal injuries. Jarrett F; Balish E; Moylan JA J Surg Res; 1978 Apr; 24(4):339-42. PubMed ID: 642502 [No Abstract] [Full Text] [Related]
17. Gap analysis of pharmacokinetics and pharmacodynamics in burn patients: a review. Steele AN; Grimsrud KN; Sen S; Palmieri TL; Greenhalgh DG; Tran NK J Burn Care Res; 2015; 36(3):e194-211. PubMed ID: 25942648 [TBL] [Abstract][Full Text] [Related]
18. [The use of aminosides in the burn patient]. Galizia JP; Besse MD; Goldstein P; Marson JC; Crépy A; Pellerin P Cah Anesthesiol; 1986 Oct; 34(6):495-9. PubMed ID: 3801960 [No Abstract] [Full Text] [Related]